Evotec SE, founded in 1993 by Manfred Eigen, is a Hamburg-based pharmaceutical company specializing in global drug discovery solutions. The company's core mission is to accelerate the development of innovative therapies across various medical fields, including neuroscience, diabetes, pain and inflammation, oncology, infectious diseases, respiratory conditions, and fibrosis. Evotec serves a global market, partnering with pharmaceutical and biotechnology companies to provide comprehensive research and development services.
Notable figures associated with Evotec include its founder, Nobel laureate Manfred Eigen. The company is publicly traded on multiple stock exchanges, including FWB and Nasdaq. Key achievements include significant advancements in drug discovery and numerous strategic partnerships with leading pharmaceutical firms. Evotec's impact is marked by its contribution to accelerating therapeutic innovations and enhancing the efficiency of drug development processes worldwide.
